Eargo (EAR) Stock Analysis
NASDAQHealthcareMedical - Devices
What Eargo does
Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Key metrics
ETFs linked to EAR
Broad-market and Healthcare sector ETFs an investor holding Eargo is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how EAR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze EAR in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Eargo?
- Eargo trades under the ticker EAR on NASDAQ.
- Which exchange is EAR listed on?
- EAR is listed on NASDAQ.
- What sector does Eargo operate in?
- Eargo is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze EAR in a portfolio?
- PortView shows EAR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.